Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Work In Process (2016 - 2020)

Myomo posted quarterly Work In Process of $606517.0 for Q1 2020, up 31.59% year-on-year from $460912.0 in Q2 2019, and up 36.83% on a QoQ basis from $443268.0 in Q4 2019.

Myomo (MYO) has 5 years of Work In Process data on file, last reported at $606517.0 in Q1 2020.

  • For the quarter ending Q1 2020, Work In Process rose 31.59% year-over-year to $606517.0; the trailing twelve-month figure through Mar 2020 stood at $606517.0 (up 31.59% YoY), and the FY2019 full-year result was $443268.0, up 33.86% from the prior year.
  • Work In Process for Q1 2020 stood at $606517.0, up from $443268.0 in the prior quarter.
  • Across five years, Work In Process topped out at $606517.0 in Q1 2020 and bottomed at $82435.0 in Q4 2016.
  • The 5-year median for Work In Process is $341664.0 (2018), against an average of $357888.6.
  • The widest annual swing landed in 2017, when Work In Process soared 195.4%; it then grew 17.04% in 2019.
  • A 5-year view of Work In Process shows it stood at $82435.0 in 2016, then jumped by 195.4% to $243510.0 in 2017, then soared by 35.99% to $331149.0 in 2018, then soared by 33.86% to $443268.0 in 2019, then jumped by 36.83% to $606517.0 in 2020.
  • The last three Work In Process figures came in at $606517.0 (Q1 2020), $443268.0 (Q4 2019), and $454379.0 (Q3 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 606,517.00
Dec 31, 2019 443,268.00
Sep 30, 2019 454,379.00
Jun 30, 2019 373,196.00
Mar 31, 2019 460,912.00
Dec 31, 2018 331,149.00
Sep 30, 2018 341,664.00
Jun 30, 2018 318,866.00
Mar 31, 2018 280,879.00
Dec 31, 2017 243,510.00
Dec 31, 2016 82,435.00